ES2098325T3 - Tratamiento de cataratas con compuestos de prostaciclina. - Google Patents

Tratamiento de cataratas con compuestos de prostaciclina.

Info

Publication number
ES2098325T3
ES2098325T3 ES91306768T ES91306768T ES2098325T3 ES 2098325 T3 ES2098325 T3 ES 2098325T3 ES 91306768 T ES91306768 T ES 91306768T ES 91306768 T ES91306768 T ES 91306768T ES 2098325 T3 ES2098325 T3 ES 2098325T3
Authority
ES
Spain
Prior art keywords
treatment
prostacicline
cataracts
compounds
cataract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91306768T
Other languages
English (en)
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ES2098325T3 publication Critical patent/ES2098325T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

USO DE UN COMPUESTO DE PROSTACICLINA PARA LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE CATARATAS.
ES91306768T 1990-08-02 1991-07-24 Tratamiento de cataratas con compuestos de prostaciclina. Expired - Lifetime ES2098325T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20645090 1990-08-02

Publications (1)

Publication Number Publication Date
ES2098325T3 true ES2098325T3 (es) 1997-05-01

Family

ID=16523576

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91306768T Expired - Lifetime ES2098325T3 (es) 1990-08-02 1991-07-24 Tratamiento de cataratas con compuestos de prostaciclina.

Country Status (11)

Country Link
US (1) US5162370A (es)
EP (1) EP0469782B1 (es)
JP (1) JPH07100656B2 (es)
KR (1) KR0157991B1 (es)
AT (1) ATE146964T1 (es)
CA (1) CA2048245C (es)
DE (1) DE69123892T2 (es)
DK (1) DK0469782T3 (es)
ES (1) ES2098325T3 (es)
GR (1) GR3022217T3 (es)
TW (1) TW205508B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224942B (es) * 1990-04-04 1994-06-11 Adka Ueno Kk
TW205508B (es) * 1990-08-02 1993-05-11 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
SE9303627D0 (sv) * 1993-11-03 1993-11-03 Kabi Pharmacia Ab Method and means for prevention of cataract
AU734650B2 (en) 1996-05-07 2001-06-21 Toray Industries, Inc. Ophthalmic preparations
RU2020124373A (ru) * 2017-12-28 2022-01-28 Юниверсити Оф Фукуи Профилактический агент и/или терапевтический агент для катаракты, медицинский состав для предотвращения и/или лечения катаракты, применение ppar-активатора для тех же целей и глазные капли

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2912409A1 (de) * 1978-03-31 1979-10-11 Ono Pharmaceutical Co 6,9-methano-pgi tief 2 -analoge
DE3477776D1 (en) * 1983-08-19 1989-05-24 Sagami Chem Res Bicycloû3.3.0¨octane derivative and preparation thereof
JPS62234085A (ja) * 1985-12-18 1987-10-14 Sankyo Co Ltd チアゾリジン誘導体を有効成分とする糖尿病性合併症治療剤
TW224942B (es) * 1990-04-04 1994-06-11 Adka Ueno Kk
TW205508B (es) * 1990-08-02 1993-05-11 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo

Also Published As

Publication number Publication date
JPH054923A (ja) 1993-01-14
CA2048245A1 (en) 1992-02-03
DE69123892D1 (de) 1997-02-13
DK0469782T3 (da) 1997-01-20
KR920003972A (ko) 1992-03-27
EP0469782A2 (en) 1992-02-05
ATE146964T1 (de) 1997-01-15
EP0469782A3 (en) 1993-01-13
JPH07100656B2 (ja) 1995-11-01
DE69123892T2 (de) 1997-04-30
KR0157991B1 (ko) 1998-12-01
CA2048245C (en) 2003-01-07
US5162370A (en) 1992-11-10
EP0469782B1 (en) 1997-01-02
GR3022217T3 (en) 1997-04-30
TW205508B (es) 1993-05-11

Similar Documents

Publication Publication Date Title
TW249226B (es)
ES2093361T3 (es) Tratamiento de enfermedades neurodegenerativas.
GR3021777T3 (en) A pharmaceutical solution comprising derivatives of FK506
DK0435443T3 (da) Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
DK0503887T3 (da) Fremme af sårheling med 15-ketoprostaglandinforbindelser
ES2089136T3 (es) Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas.
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
ES2098325T3 (es) Tratamiento de cataratas con compuestos de prostaciclina.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
AU639322B2 (en) Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 469782

Country of ref document: ES